Cargando…

An Individual’s Lived Experiences of Taking Cannabis-Based Medicinal Products (CBMPs) to Treat Anxiety

This report documents the case of a patient (the author) participating in a clinical trial of medical cannabis (Cannabis sativa L.)—the Sapphire Access Scheme, run by the Sapphire Medical Clinic as part of the UK Medical Cannabis Registry—to explore the impacts of cannabis-based medicinal products (...

Descripción completa

Detalles Bibliográficos
Autor principal: Hurn, Samantha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530413/
https://www.ncbi.nlm.nih.gov/pubmed/37754635
http://dx.doi.org/10.3390/ijerph20186776
_version_ 1785111512536317952
author Hurn, Samantha
author_facet Hurn, Samantha
author_sort Hurn, Samantha
collection PubMed
description This report documents the case of a patient (the author) participating in a clinical trial of medical cannabis (Cannabis sativa L.)—the Sapphire Access Scheme, run by the Sapphire Medical Clinic as part of the UK Medical Cannabis Registry—to explore the impacts of cannabis-based medicinal products (CBMPs) on anxiety. For most of my life, I have experienced often very serious bouts of poor mental health arising, in part, from childhood abuse, and have been diagnosed with several mental health conditions which constitute disabilities. I have received various conventional treatments and multiple alternative therapies. However, none of these have enabled me to consistently manage my conditions long-term, and I often suffer relapses. As part of the Sapphire Access Scheme, I complete regular quantitative questionnaires regarding the impacts of the CBMPs on my anxiety and have also obtained the clinic’s permission to qualitatively document and write up the impacts of CBMPs on my mental health. Here, I present a preliminary autoethnographic exploration of my lived experiences of CBMP use over the first four months of the trial, which show that even within such a short space of time, CBMPs have had a positive impact on treating what had previously been treatment-refractive chronic anxiety.
format Online
Article
Text
id pubmed-10530413
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105304132023-09-28 An Individual’s Lived Experiences of Taking Cannabis-Based Medicinal Products (CBMPs) to Treat Anxiety Hurn, Samantha Int J Environ Res Public Health Case Report This report documents the case of a patient (the author) participating in a clinical trial of medical cannabis (Cannabis sativa L.)—the Sapphire Access Scheme, run by the Sapphire Medical Clinic as part of the UK Medical Cannabis Registry—to explore the impacts of cannabis-based medicinal products (CBMPs) on anxiety. For most of my life, I have experienced often very serious bouts of poor mental health arising, in part, from childhood abuse, and have been diagnosed with several mental health conditions which constitute disabilities. I have received various conventional treatments and multiple alternative therapies. However, none of these have enabled me to consistently manage my conditions long-term, and I often suffer relapses. As part of the Sapphire Access Scheme, I complete regular quantitative questionnaires regarding the impacts of the CBMPs on my anxiety and have also obtained the clinic’s permission to qualitatively document and write up the impacts of CBMPs on my mental health. Here, I present a preliminary autoethnographic exploration of my lived experiences of CBMP use over the first four months of the trial, which show that even within such a short space of time, CBMPs have had a positive impact on treating what had previously been treatment-refractive chronic anxiety. MDPI 2023-09-18 /pmc/articles/PMC10530413/ /pubmed/37754635 http://dx.doi.org/10.3390/ijerph20186776 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Hurn, Samantha
An Individual’s Lived Experiences of Taking Cannabis-Based Medicinal Products (CBMPs) to Treat Anxiety
title An Individual’s Lived Experiences of Taking Cannabis-Based Medicinal Products (CBMPs) to Treat Anxiety
title_full An Individual’s Lived Experiences of Taking Cannabis-Based Medicinal Products (CBMPs) to Treat Anxiety
title_fullStr An Individual’s Lived Experiences of Taking Cannabis-Based Medicinal Products (CBMPs) to Treat Anxiety
title_full_unstemmed An Individual’s Lived Experiences of Taking Cannabis-Based Medicinal Products (CBMPs) to Treat Anxiety
title_short An Individual’s Lived Experiences of Taking Cannabis-Based Medicinal Products (CBMPs) to Treat Anxiety
title_sort individual’s lived experiences of taking cannabis-based medicinal products (cbmps) to treat anxiety
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530413/
https://www.ncbi.nlm.nih.gov/pubmed/37754635
http://dx.doi.org/10.3390/ijerph20186776
work_keys_str_mv AT hurnsamantha anindividualslivedexperiencesoftakingcannabisbasedmedicinalproductscbmpstotreatanxiety
AT hurnsamantha individualslivedexperiencesoftakingcannabisbasedmedicinalproductscbmpstotreatanxiety